Imaging of Interventional Therapies in Oncology: Computed Tomography

  • David J. Grand
Reference work entry


Computed tomography (CT), particularly multi-detector CT (MDCT), rapidly provides exquisite diagnostic information. Continued growth of percutaneous oncologic therapies requires detailed understanding of the CT appearance of tumors both before and after treatment. The purpose of this chapter is to familiarize the radiologist with current techniques for tumor diagnoses as well as well as posttreatment evaluation of percutaneously treated lesions.


Renal Cell Carcinoma Pulmonary Nodule Renal Mass Ablation Zone Portal Venous Phase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Menezes RJ, Roberts HC, Paul NS, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer. 2010;67:177–83.CrossRefPubMedGoogle Scholar
  2. 2.
    Fujikawa A, Takiguchi Y, Mizuno S, et al. Lung cancer screening – comparison of computed tomography and X-ray. Lung Cancer. 2006;61:195–201.CrossRefGoogle Scholar
  3. 3.
    Diederich S, Thomas M, Semik M, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up; examinations in asymptomatic smokers. Eur Radiol. 2004;14:691–702.CrossRefPubMedGoogle Scholar
  4. 4.
    Crosswell JM, Baker SG, Marcus PM, et al. Cumulative incidence of false-positive test results in lung cancer screening. Ann Intern Med. 2010;152(8):505–12.CrossRefGoogle Scholar
  5. 5.
    Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? Chest. 2007;132:94S–107.CrossRefPubMedGoogle Scholar
  6. 6.
    MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237(2):395–400.CrossRefPubMedGoogle Scholar
  7. 7.
    Swenson SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology. 2000;214:73–80.CrossRefGoogle Scholar
  8. 8.
    Angliviel B, Benoist S, Penna C, El Hajjam M, Chagnon S, Julie C, Beauchet A, Rougier P, Nordlinger B. Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann Surg Oncol. 2009;16:1247–53.CrossRefPubMedGoogle Scholar
  9. 9.
    Yates CK, Streight RA. Focal fatty infiltration of the liver simulating metastatic disease. Radiology. 1986;159:83–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Kim MJ, Choi JY, Lim JS, et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. AJR. 2006;187(1):198–206.CrossRefPubMedGoogle Scholar
  11. 11.
    Motosugi U, Ichikawa T, Nakajima H, et al. Cholangiolocellular carcinoma of the liver: imaging findings. J Comput Assist Tomogr. 2009;33(5):682–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Ch’en IY, Katz DS, Jeffrey Jr RB, Daniel BL, Li KC, Beaulieu CF, Mindelzun RE, Yao D, Olcott EW. Do arterial phase helical CT images improve detection or characterization of colorectal liver metastases? J Comput Assist Tomogr. 1997;21(3):391–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, Valleur P, Rymer R. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology. 2004;341:413–20.CrossRefGoogle Scholar
  14. 14.
    Smith SJ, Bosniak MA, Megibow AJ, et al. Renal cell carcinoma. Earlier discovery and increased detection. Radiology. 1989;170:699–703.CrossRefPubMedGoogle Scholar
  15. 15.
    Kopka L, Fischer U, Zoeller G, et al. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR. 1997;169:1573–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Silverman SG, Israel GM, Herts BR, et al. Management of the incidental renal mass. Radiology. 2008;249(1):16–31.CrossRefPubMedGoogle Scholar
  17. 17.
    Israel GM, Bosniak MA. An update of the bosniak renal cyst classification system. Urology. 2005;66:484–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Wolf FJ, Grand DJ, Machan JT. Microwave ablation of lung malignancies: effectiveness, CT findings and safety in 50 patients. Radiology. 2008;247:871–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Okuma T, Matsuoka T, Yamamoto A. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol. 2007;18:399–404.CrossRefPubMedGoogle Scholar
  20. 20.
    Bojarski JD, Dupuy DE, Mayo-Smith WM. CT imaging findings of pulmonary neoplasm after treatment with radiofrequency ablation: results in 32 tumors. AJR. 2005;185:466–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007;18:393–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Goldberg SN, Grassi C, Cardella J, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2005;16:765–78.CrossRefPubMedGoogle Scholar
  23. 23.
    Schraml C, Clasen S, Schwenzer NF. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging. 2008;33:643–51.CrossRefPubMedGoogle Scholar
  24. 24.
    Muller S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158–71.CrossRefGoogle Scholar
  25. 25.
    Chen CY, Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants – initial experience. Radiology. 2006;239(2):448–56.CrossRefPubMedGoogle Scholar
  26. 26.
    Cady B, Jenkins RL, Steele Jr GD, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;277:566–71.CrossRefGoogle Scholar
  27. 27.
    Chopra S, Dodd GD, Chintapalli KN. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR. 2001;177:381–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Davenport MS, Caoili EM, Cohan RH, et al. MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation. AJR. 2009;192:1571–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Wile GE, Leyendecker JR, Krehbiel KA, et al. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics. 2007;27:325–41.CrossRefPubMedGoogle Scholar
  30. 30.
    Schirmang TC, Mayo-Smith WW, Dupuy DE, et al. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation – incidence and clinical importance in 101 consecutive patients. Radiology. 2009;253:263–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Diagnostic Radiology, Warren Alpert School of MedicineBrown UniversityProvidenceUSA

Personalised recommendations